T. Rowe Price Associates’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77B Buy
17,277,212
+2,558,058
+17% +$289M 0.21% 100
2025
Q4
$1.84B Sell
14,719,154
-1,081,605
-7% -$138M 0.2% 95
2025
Q3
$2.12B Buy
15,800,759
+5,451,244
+53% +$716M 0.23% 77
2025
Q2
$1.41B Buy
10,349,515
+6,178,992
+148% +$815M 0.16% 123
2025
Q1
$553M Buy
4,170,523
+375,168
+10% +$47.7M 0.07% 255
2024
Q4
$429M Sell
3,795,355
-255,146
-6% -$29.5M 0.05% 293
2024
Q3
$462M Sell
4,050,501
-11,974
-0.3% -$1.31M 0.05% 291
2024
Q2
$422M Sell
4,062,475
-74,697
-2% -$7.92M 0.05% 302
2024
Q1
$470M Sell
4,137,172
-155,691
-4% -$17.8M 0.06% 280
2023
Q4
$473M Sell
4,292,863
-49
-0% -$4.9K 0.06% 268
2023
Q3
$416M Sell
4,292,912
-32,026
-0.7% -$3.36M 0.06% 264
2023
Q2
$472M Buy
4,324,938
+219,349
+5% +$23.4M 0.07% 258
2023
Q1
$416M Sell
4,105,589
-170,712
-4% -$18M 0.06% 266
2022
Q4
$469M Sell
4,276,301
-5,950,387
-58% -$616M 0.08% 241
2022
Q3
$990M Buy
10,226,688
+813,894
+9% +$86.7M 0.16% 126
2022
Q2
$1.02B Buy
9,412,794
+1,074,432
+13% +$122M 0.13% 168
2022
Q1
$987M Buy
8,338,362
+2,663,477
+47% +$330M 0.1% 206
2021
Q4
$799M Sell
5,674,885
-823,241
-13% -$105M 0.07% 265
2021
Q3
$768M Sell
6,498,126
-2,199,778
-25% -$270M 0.07% 269
2021
Q2
$1.01B Sell
8,697,904
-1,703,604
-16% -$199M 0.09% 226
2021
Q1
$1.25B Buy
10,401,508
+6,413,312
+161% +$760M 0.12% 181
2020
Q4
$437M Sell
3,988,196
-86,409
-2% -$9.39M 0.04% 354
2020
Q3
$443M Sell
4,074,605
-914,357
-18% -$92.8M 0.05% 319
2020
Q2
$456M Sell
4,988,962
-504,577
-9% -$45.6M 0.06% 308
2020
Q1
$434M Buy
5,493,539
+452,690
+9% +$37.8M 0.07% 278
2019
Q4
$438M Sell
5,040,849
-2,538,512
-33% -$213M 0.06% 324
2019
Q3
$634M Buy
7,579,361
+227,561
+3% +$19.3M 0.09% 238
2019
Q2
$618M Sell
7,351,800
-2,926,566
-28% -$230M 0.09% 242
2019
Q1
$822M Sell
10,278,366
-5,567,479
-35% -$414M 0.12% 179
2018
Q4
$1.15B Sell
15,845,845
-1,116,321
-7% -$78.5M 0.19% 125
2018
Q3
$1.24B Sell
16,962,166
-1,854,657
-10% -$122M 0.18% 131
2018
Q2
$1.15B Sell
18,816,823
-782,136
-4% -$47.4M 0.18% 131
2018
Q1
$1.17B Sell
19,598,959
-6,074,528
-24% -$366M 0.19% 121
2017
Q4
$1.47B Sell
25,673,487
-1,964,743
-7% -$109M 0.24% 98
2017
Q3
$1.47B Sell
27,638,230
-1,421,915
-5% -$71.3M 0.25% 95
2017
Q2
$1.41B Buy
29,060,145
+1,443,883
+5% +$65.4M 0.25% 98
2017
Q1
$1.23B Sell
27,616,262
-5,802,467
-17% -$251M 0.23% 112
2016
Q4
$1.28B Buy
33,418,729
+627,513
+2% +$24.9M 0.25% 93
2016
Q3
$1.39B Buy
32,791,216
+3,272,839
+11% +$140M 0.28% 84
2016
Q2
$1.16B Buy
29,518,377
+6,213,260
+27% +$247M 0.25% 102
2016
Q1
$975M Buy
23,305,117
+7,099,793
+44% +$281M 0.21% 126
2015
Q4
$728M Buy
16,205,324
+764,966
+5% +$33.8M 0.15% 158
2015
Q3
$621M Buy
15,440,358
+1,410,470
+10% +$66.5M 0.14% 175
2015
Q2
$689M Buy
14,029,888
+829,392
+6% +$39.8M 0.14% 161
2015
Q1
$612M Sell
13,200,496
-223,168
-2% -$10.2M 0.13% 193
2014
Q4
$604M Buy
13,423,664
+3,652,595
+37% +$159M 0.13% 198
2014
Q3
$406M Buy
9,771,069
+711,670
+8% +$30.1M 0.09% 262
2014
Q2
$371M Buy
9,059,399
+3,033,770
+50% +$119M 0.08% 296
2014
Q1
$232M Buy
6,025,629
+15,730
+0.3% +$606K 0.05% 404
2013
Q4
$230M Sell
6,009,899
-115,533
-2% -$4.26M 0.05% 395
2013
Q3
$203M Sell
6,125,432
-974,430
-14% -$34.2M 0.05% 397
2013
Q2
$248M Buy
+7,099,862
New +$260M 0.07% 344

Other funds holding ABT

T. Rowe Price Associates's ABT Position: Q1 2026 in Review

T. Rowe Price Associates increased its Abbott (ABT) stake by 17% in Q1 2026, buying an estimated $289M and bringing the position to 17,277,212 shares worth $1.77B. The position accounts for 0.21% of the portfolio, ranked #100.

T. Rowe Price Associates first reported a position in ABT in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.12B in Q3 2025. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • T. Rowe Price Associates held 17,277,212 shares of Abbott worth $1.77B as of Q1 2026.
  • T. Rowe Price Associates bought 2,558,058 Abbott shares in Q1 2026, an estimated $289M.
  • Abbott made up 0.21% of T. Rowe Price Associates's portfolio in Q1 2026, its #100 holding.
  • T. Rowe Price Associates first reported a position in Abbott in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Abbott position peaked at $2.12B in Q3 2025.
  • 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.